Primary results of NRG-RTOG1106/ECOG-ACRIN 6697: A randomized phase II trial of individualized adaptive (chemo)radiotherapy using midtreatment (18)F-fluorodeoxyglucose positron emission tomography/computed tomography in stage III non–small cell lung cancer Journal Article


Authors: Kong, F. M.; Hu, C.; Pryma, D. A.; Duan, F.; Matuszak, M.; Xiao, Y.; Ten Haken, R.; Siegel, M. J.; Hanna, L.; Curran, W. J.; Dunphy, M.; Gelblum, D.; Piert, M.; Jolly, S.; Robinson, C. G.; Quon, A.; Loo, B. W.; Srinivas, S.; Videtic, G. M.; Faria, S. L.
Article Title: Primary results of NRG-RTOG1106/ECOG-ACRIN 6697: A randomized phase II trial of individualized adaptive (chemo)radiotherapy using midtreatment (18)F-fluorodeoxyglucose positron emission tomography/computed tomography in stage III non–small cell lung cancer
Journal Title: Journal of Clinical Oncology
Volume: 42
Issue: 33
ISSN: 0732-183X
Publisher: American Society of Clinical Oncology  
Date Published: 2024-11-20
Start Page: 3935
End Page: 3946
Language: English
DOI: 10.1200/jco.24.00022
PROVIDER: EBSCOhost
PROVIDER: cinahl plus with full text
PUBMED: 39365957
PMCID: PMC11781790
DOI/URL:
Notes: Accession Number: 180931304 -- Entry Date: In Process -- Revision Date: 20241119 -- Publication Type: Journal Article -- Journal Subset: Biomedical; Editorial Board Reviewed; Expert Peer Reviewed; Peer Reviewed; USA -- NLM UID: 8309333. -- Source: CINAHL Plus with Full Text
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Daphna Y Gelblum
    228 Gelblum
  2. Mark Phillip Dunphy
    81 Dunphy